Health
Scientists Identify Potential Drug Candidate Against Covid-19, Stops Virus from Replicating in Host Cells – News18
Ebselen, a chemical compound with anti-viral, anti-inflammatory, anti-oxidative, bactericidal and cell-protective properties, is used to treat bipolar disorder and loss of hearing.
Using state-of-the-art computer simulations, scientists have identified a preexisting drug, used to treat multiple diseases, including bipolar disorders and hearing loss, that could prevent the novel coronavirus from replicating in host cells, an advance that may lead to a therapeutic solution against COVID-19. The study, published in the journal Science Advances, assessed the molecule main protease, Mpro, of the novel coronavirus which is a key enzyme that plays a central role in its life cycle…
-
Noosa News18 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business23 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business22 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News19 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites